Radiofrequency ablation therapy for bone metastasis from hepatocellular carcinoma: Case report

Michihiro Maruyama; Takehide Asano; Takashi Kenmochi; Osamu Kainuma; Kotaro Iwasaki; Hideaki Miyauchi; Kenichi Saigo; Fumihiko Miura; Susumu Kobayashi; Takenori Ochiai

Radiofrequency ablation therapy for bone metastasis from hepatocellular carcinoma: Case report

Michihiro Maruyama, Takehide Asano, Takashi Kenmochi, Osamu Kainuma, Kotaro Iwasaki, Hideaki Miyauchi, Kenichi Saigo, Fumihiko Miura, Susumu Kobayashi, Takenori Ochiai

Research output: Contribution to journal › Article › peer-review

9 Citations (Scopus)

Abstract

Background: Radiofrequency ablation (RFA) is one of the standard percutaneous therapies for hepatocellular carcinoma (HCC), but RFA has not been applied to treat bone metastasis from HCC. Case: A 65-year-old male patient, who underwent hepatectomy for HCC two and a half years previously, complained of pain in his right thigh. Imaging modalities and a needle biopsy revealed metastatic HCC in his right acetabulum. The first RFA therapy was attempted under computed tomography (CT) guidance with 42 Gy radiation therapy. The second RFA therapy was performed for tumor recurrence in his pelvis at 4 years after the first RFA. Conclusion: RFA is a safe, easy, repeatable and effective therapy and should be one of the most important therapeutic modalities for bone metastasis from HCC.

Original language	English
Pages (from-to)	2987-2989
Number of pages	3
Journal	Anticancer research
Volume	23
Issue number	3 C
Publication status	Published - 05-2003
Externally published	Yes

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{c5e79b1cf7234d2fb0e3791382e3ebe9,

title = "Radiofrequency ablation therapy for bone metastasis from hepatocellular carcinoma: Case report",

abstract = "Background: Radiofrequency ablation (RFA) is one of the standard percutaneous therapies for hepatocellular carcinoma (HCC), but RFA has not been applied to treat bone metastasis from HCC. Case: A 65-year-old male patient, who underwent hepatectomy for HCC two and a half years previously, complained of pain in his right thigh. Imaging modalities and a needle biopsy revealed metastatic HCC in his right acetabulum. The first RFA therapy was attempted under computed tomography (CT) guidance with 42 Gy radiation therapy. The second RFA therapy was performed for tumor recurrence in his pelvis at 4 years after the first RFA. Conclusion: RFA is a safe, easy, repeatable and effective therapy and should be one of the most important therapeutic modalities for bone metastasis from HCC.",

author = "Michihiro Maruyama and Takehide Asano and Takashi Kenmochi and Osamu Kainuma and Kotaro Iwasaki and Hideaki Miyauchi and Kenichi Saigo and Fumihiko Miura and Susumu Kobayashi and Takenori Ochiai",

year = "2003",

month = may,

language = "English",

volume = "23",

pages = "2987--2989",

journal = "Anticancer research",

issn = "0250-7005",

publisher = "International Institute of Anticancer Research",

number = "3 C",

}

TY - JOUR

T1 - Radiofrequency ablation therapy for bone metastasis from hepatocellular carcinoma

T2 - Case report

AU - Maruyama, Michihiro

AU - Asano, Takehide

AU - Kenmochi, Takashi

AU - Kainuma, Osamu

AU - Iwasaki, Kotaro

AU - Miyauchi, Hideaki

AU - Saigo, Kenichi

AU - Miura, Fumihiko

AU - Kobayashi, Susumu

AU - Ochiai, Takenori

PY - 2003/5

Y1 - 2003/5

N2 - Background: Radiofrequency ablation (RFA) is one of the standard percutaneous therapies for hepatocellular carcinoma (HCC), but RFA has not been applied to treat bone metastasis from HCC. Case: A 65-year-old male patient, who underwent hepatectomy for HCC two and a half years previously, complained of pain in his right thigh. Imaging modalities and a needle biopsy revealed metastatic HCC in his right acetabulum. The first RFA therapy was attempted under computed tomography (CT) guidance with 42 Gy radiation therapy. The second RFA therapy was performed for tumor recurrence in his pelvis at 4 years after the first RFA. Conclusion: RFA is a safe, easy, repeatable and effective therapy and should be one of the most important therapeutic modalities for bone metastasis from HCC.

AB - Background: Radiofrequency ablation (RFA) is one of the standard percutaneous therapies for hepatocellular carcinoma (HCC), but RFA has not been applied to treat bone metastasis from HCC. Case: A 65-year-old male patient, who underwent hepatectomy for HCC two and a half years previously, complained of pain in his right thigh. Imaging modalities and a needle biopsy revealed metastatic HCC in his right acetabulum. The first RFA therapy was attempted under computed tomography (CT) guidance with 42 Gy radiation therapy. The second RFA therapy was performed for tumor recurrence in his pelvis at 4 years after the first RFA. Conclusion: RFA is a safe, easy, repeatable and effective therapy and should be one of the most important therapeutic modalities for bone metastasis from HCC.

UR - http://www.scopus.com/inward/record.url?scp=0041622635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041622635&partnerID=8YFLogxK

M3 - Article

C2 - 12926150

AN - SCOPUS:0041622635

SN - 0250-7005

VL - 23

SP - 2987

EP - 2989

JO - Anticancer research

JF - Anticancer research

IS - 3 C

ER -

Radiofrequency ablation therapy for bone metastasis from hepatocellular carcinoma: Case report

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Other files and links

Fingerprint

Cite this